TGTX Stock Summary and Trading Ideas (TG Therapeutics | NASDAQ:TGTX)

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases. In addition to a research pipeline, it has received approval from the U.S. Food and Drug Administration (FDA) for BRIUMVI (ublituximab-xiiy) to treat adult patients with relapsing forms of multiple sclerosis (RMS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as approval from several regulatory agencies outside of the U.S. Its pipeline includes UBLITUXIMAB, SUB-Q UBLITUXIMAB, and AZER-CEL. Geographically, it generates a majority of its revenue selling BRIUMVI in the United States, with the rest coming from the international market.

TG Therapeutics trades on the NASDAQ stock market under the symbol TGTX.

As of April 6, 2026, TGTX stock price climbed to $33.69 with 1,950,534 million shares trading.

TGTX has a beta of 0.57, meaning it tends to be less sensitive to market movements. TGTX has a correlation of 0.04 to the broad based SPY ETF.

TGTX has a market cap of $5.35 billion. This is considered a Mid Cap stock.

Last quarter TG Therapeutics reported $193 million in Revenue and $.14 earnings per share. This beat revenue expectation by $807,588 and missed earnings estimates by -$.20.

In the last 3 years, TGTX traded as high as $46.48 and as low as $6.46.

The top ETF exchange traded funds that TGTX belongs to (by Net Assets): IJR, VTI, IWM, XBI, VB.

TGTX has underperformed the market in the last year with a return of -15.4%, while SPY returned +18.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in TGTX shares. However, TGTX has outperformed the market in the last 3 month and 2 week periods, returning +15.1% and +11.0%, while SPY returned -3.3% and +0.4%, respectively. This indicates TGTX has been having a stronger performance recently.

TGTX support price is $32.44 and resistance is $34.62 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that TGTX shares will trade within this expected range on the day.